Home » Topics » BioWorld Science

BioWorld Science
RSS

MicroRNA switch therapy self-assembles into nanoparticles to treat atherosclerosis

Feb. 26, 2021

Italian researchers present new PTPN11 inhibitors

Feb. 26, 2021

Amgen discovers new KIF18A inhibitors

Feb. 26, 2021

First patient dosed in phase III study of eftansomatropin alfa in China

Feb. 26, 2021

Janssen Pharmaceutica synthesizes new compounds for HBV infection

Feb. 26, 2021

Gene variants can increase fat, decrease cardiometabolic risk

Feb. 26, 2021

Well Marker Bio presents new MST1R inhibitors

Feb. 26, 2021

Repure Life Science patents p300 inhibitors

Feb. 26, 2021

Initiation of phase IIa study evaluating BGE-117 in elderly with unexplained anemia

Feb. 26, 2021

ESSA Pharma and Astellas collaborate to investigate EPI-7386 plus enzalutamide in mCRPC

Feb. 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...